The Digital Apothecary
JUNE 5, 2020
I have been relatively quiet for the past few months here, and I'd like to write about my recent experiences of navigating a pandemic with a newborn. To be frank, it's been a hectic ride. Third Trimester is Fun. Unless You're Panicking My wife entered the third trimester in February, by which time the news regarding how bad COVID-19 was going to be was a bit difficult.
Pharma Marketing Network
JUNE 4, 2020
Marketing is challenging in these days of COVID-19 because each person and business is experiencing the virus in different ways. All are impacted and all are (trying) to adapt. Some are suffering, some are growing. Regardless of if you’re suffering or growing right now, you’re likely anxious and fearful about what will come next, and likely feeling more isolated than ever before, even if you’re more engaged than others.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Packaging Solutions
JUNE 4, 2020
In the May issue of Tablets and Capsules, our own Scott Garverick, weighs in on the cover topic – “Packaging Sustainability.” The money quote from Scott is “We ensure that our waste paperboard is recycled into print media, packaging, and folding carton stock… Also, we have led a number of companies from 3-ply corrugated materials to single-sheet substrates as a component of our green packaging initiative.” We are sharing the article below and you can also link
Drug Channels
JUNE 3, 2020
The Bureau of Labor Statistics (BLS) recently released its employment data for 2019. That means it’s time to update our annual Drug Channels analysis of pharmacist salaries and employment. Average base salaries were about $125,000, though there was substantial variation across practice settings. Total pharmacist employment grew in 2019. Consistent with our previous analyses, the share of pharmacists who work at hospitals reached a new high.
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Pharma in Brief
JUNE 4, 2020
This week has seen a number of developments relating to the Patented Medicine Prices Review Board ( PMPRB ), including a six-month delay to the implementation of amendments to the Patented Medicines Regulations and renewed consultation by the Board on revised Draft Guidelines to implement those amendments. Meanwhile, the Federal Court is now considering a judicial review of those amendments.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Med Ed 101
JUNE 3, 2020
Parkinson’s disorder can be incredibly challenging to manage. The progression of the disease and its complications can make Parkinson’s very difficult for patients and clinicians. In addition to the disease itself, medication administration in Parkinson’s can provide additional hurdles to navigate. Here are some of the most common challenges I’ve seen in clinical practice associated […].
Drug Channels
JUNE 1, 2020
Like many of you, I was disappointed that Asembia had to cancel its 2020 Specialty Pharmacy Summit. As a small consolation, Asembia is providing a series of on-demand business sessions. You can view them for FREE if your registration to the 2020 Specialty Pharmacy Summit was transferred to the 2021 Summit. Everyone else will have to pay a small fee.
Pharma in Brief
JUNE 1, 2020
The Federal Court has dismissed two infringement actions brought against defendants under subsection 6(1) of the Patented Medicines (Notice of Compliance) Regulations ( Regulations ), following a common trial on the validity of Canadian Patent No. 2,562,277 ( 277 Patent ). The Court found that all the asserted claims – to uses for treating multiple sclerosis ( MS ) – were obvious and that some were anticipated.
Pharmacy Joe
MAY 31, 2020
In this episode, I’ll discuss the two scenarios where asymptomatic bacteriuria (ASB) is treated with antibiotics in adult patients. Episode 509: Two scenarios where asymptomatic bacteriuria is treated in adult patients without symptoms Subscribe on iTunes , Android , or Stitcher Considerable focus has appropriately been placed on reducing unnecessary antibiotic use in patients with otherwise asymptomatic bacteriuria.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Med Ed 101
MAY 31, 2020
I’m extremely grateful for the many pharmacists who have stepped up and provided education on topics they are passionate about. I’ve touched on QT prolongation in the past, but Daniel Lieu, PharmD has taken it up a notch! He has provided some spot-on education below on QT Prolongation for Community Pharmacists that can be applied […].
Pharma in Brief
JUNE 2, 2020
The Federal Court of Appeal ( FCA ) and the Federal Court ( FC ) have extended their Suspension Periods to June 15, 2020. Federal Court of Appeal. On May 28, 2020, the FCA issued a Notice to the Parties and the Profession extending the Suspension Period to June 15, 2020. Federal Court. On May 29, 2020, the FC issued an updated Practice Direction and Order ( FC Update ), also extending the Suspension Period to June 15, 2020.
Expert insights. Personalized for you.
130 
Let's personalize your content